The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.
about
Effect of drug reminder packaging on medication adherence: a systematic review revealing research gapsMultidrug punch cards in primary care: a mixed methods study on patients' preferences and impact on adherence.Clinical outcomes and adherence to medications measured by claims data in patients with diabetesUnderstanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE ProjectCost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France.The complex relation between bisphosphonate adherence and fracture reduction.A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs.Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in ViennaThe pace of change in medical practice and health policy: collision or coexistence?Success of a sustained pharmaceutical care service with electronic adherence monitoring in patient with diabetes over 12 months.Desirability and feasibility of wireless electronic monitoring of medications in clinical trialsCompliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients.Assessing generalisability in model-based economic evaluation studies: a structured review in osteoporosis.The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determBlood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review.Adjuvant Endocrine Therapy in Breast Cancer: A Novel e-Health Approach in Optimizing Treatment for Seniors (OPTIMUM): A Two-Group Controlled Comparison Pilot Study.Increasing the detection and response to adherence problems with cardiovascular medication in primary care through computerized drug management systems: a randomized controlled trial.Duloxetine treatment adherence across mental health and chronic pain conditions.Economic impact of poor compliance with pharmaceuticals.Estimating the cost effectiveness of alternative drug treatments for postmenopausal osteoporosis.Potential of St John's Wort for the treatment of depression: the economic perspective.The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review.Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.Adherence in adults with type 1 diabetes mellitus correlates with treatment satisfaction but not with adverse events.When is it worth introducing a quality improvement program? A mathematical model.How much does it cost to change the behavior of health professionals? A mathematical model and an application to academic detailing.Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease.Assessment of adherence measures with different stimulants among children and adolescents.Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity.Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone.[Drug treatment of cystic fibrosis - cost patterns and savings potential for outpatient treatment].Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus.
P2860
Q26862555-99CBFFF3-8C99-4CBF-B22B-E04DBBD941FAQ30588645-FF59D9A5-BB6C-4F77-90AF-EA75D2E3F3FBQ30977056-4C63851C-A5A6-42E3-A5A3-741F59F7D657Q33844202-2D614305-8BAF-49EA-AF3E-939E62628720Q33942472-611AD60C-5270-4A76-915C-211C8C0E2223Q34086612-F459D316-B580-4331-B33B-8E50715D11DAQ35011267-CFD72C17-D1B8-4E7E-B9D0-7EAE6F56DF4DQ35198477-8FA93BF9-26B7-4EF2-AA60-D99C43D10933Q35638254-08E536D1-5ED1-443A-BEBF-C14E947B7197Q35698363-3C420D83-F0DD-42A9-8B1D-1B5CB34A6E83Q35956767-5E9C1497-7E5B-4240-9B68-98D608BB223EQ36013094-29B2737B-477F-4300-9A08-CDEA91B5A90AQ36376395-5E6927AF-896B-4CAE-801C-356A37B0FB45Q36439111-88E5F480-7005-4198-9A27-B181245F4AEDQ36573967-F2E77DA1-5A9E-46CC-8F82-D45BD468BB3EQ36621460-794DC722-E0C5-4631-8935-696240D7F82AQ37159292-98AF3F12-5F92-4337-B677-31DE77EB13B5Q37427773-6D5B99A7-E4D4-4710-9F18-003C0F7AA0C9Q37578932-A3B11C3B-0534-4662-9A41-5337C70280A2Q37595422-C8D400C4-D1AF-4961-A1B5-6BAB6B6C5C42Q37609268-FFA8EF6E-A272-4A9F-A771-70D2B02BCD98Q37609360-61005FEC-9808-4C29-8036-D970CF7D5D9CQ37803219-2B485F87-B2E7-474A-8C00-B9E92AF89687Q37998122-798BAB67-452F-47F2-B6CC-63C37B9D19E4Q38085227-D7BCDC87-04A0-4568-B983-CEB878B72CFCQ38598776-32C67579-627A-4FF3-B26D-07FA35A4AFEDQ41835397-61A82C5E-A9AA-48C3-BB74-93A1C226809BQ41925490-138C8811-80CF-4441-A973-4366EB182B15Q41994238-13D8E8CE-DFC9-43D3-8B29-5F6A3DB8F900Q44690911-1E5451CA-5FE1-4806-81E8-B9070C771BF1Q45296818-54BBFEA7-C0EF-458C-9F67-3CE1AF7A2E48Q45331432-5FA35000-9F8F-4DED-A51B-B3BD81343876Q46592039-72254025-4ABC-48E0-A363-DF255A9D1626Q48302711-D81E9588-0157-44ED-A39B-B206B3B34308Q50694057-979351D2-94E2-4334-89FD-CC8BAF7F4A23Q51157350-BDE4B0EF-A30D-4E26-B602-4592F324DE3DQ51313958-E0887EC0-4094-4779-9421-CD586EA44B94
P2860
The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The impact of non-compliance o ...... s: a review of the literature.
@ast
The impact of non-compliance o ...... s: a review of the literature.
@en
The impact of non-compliance o ...... s: a review of the literature.
@nl
type
label
The impact of non-compliance o ...... s: a review of the literature.
@ast
The impact of non-compliance o ...... s: a review of the literature.
@en
The impact of non-compliance o ...... s: a review of the literature.
@nl
prefLabel
The impact of non-compliance o ...... s: a review of the literature.
@ast
The impact of non-compliance o ...... s: a review of the literature.
@en
The impact of non-compliance o ...... s: a review of the literature.
@nl
P2093
P2860
P356
P1433
P1476
The impact of non-compliance o ...... ls: a review of the literature
@en
P2093
P2860
P304
P356
10.1002/HEC.609
P407
P577
2001-10-01T00:00:00Z